Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01700738
Other study ID # 2012 - A00555-38
Secondary ID
Status Not yet recruiting
Phase Phase 4
First received October 2, 2012
Last updated October 2, 2012
Start date November 2012
Est. completion date November 2015

Study information

Verified date October 2012
Source University Hospital, Angers
Contact REGIS COUTANT
Email recoutant@chu-angers.fr
Is FDA regulated No
Health authority France: Committee for the Protection of Personnes
Study type Interventional

Clinical Trial Summary

MAIN OBJECTIVE To compare the effects of the placement of an adjustable gastric band with "conventional" treatment of obesity.

SECONDARY OBJECTIVES

- Compare the effects of the placement of a gastric band with "conventional" treatment of obesity on quality of life, body composition and parameters of the metabolic syndrome.

- Identify predictors of "good answer to the ring" to determine the best future indications.

- Study of the gastric tolerance.

INCLUSION CRITERIA

1. Adolescents 12 to 16 years and with BMI and weight gain according to sex and age is greater than IMCZ-score > 4 DP> 8 kg

2. Obesity "common" non-syndromic.

3. Medical decision of surgical placement of laparoscopic gastric banding.

4. Adolescent and family who understand and accept the need for medical and surgical follow long term.

5. Adolescent and family who fully understood the oral and written information explaining the study and the need for prolonged follow-up.

6. Obtention of oral and written consent of the adolescent and the parents.

7. Parents and adolescents affiliated with the social security system.

NONINCLUSION CRITERIA

1. Intellectual Deficit.

2. psychiatrics contraindication of surgical placement of laparoscopic gastric banding.

3. Obesity with severe binge eating.

4. Pregnancy or wishes of pregnancy in the following year.

5. Non accession adolescent and / or family in the process of medical care before inclusion.

6. Predictable post surgical monitoring difficulties.

7. Suspicion of physical abuse, verbal or negligence / deficiency in care of the family.

8. Participation in a clinical study evaluating a treatment during the 2 years of the study.

EXCLUSION CRITERIA

1. Anesthetic contre indication for placement of a gastric laparoscopic.

2. IMC> 50 kg/m2 the day of inclusion.

STRATEGIES / PROCEDURES During a routine visit, the study will be presented to the patient and his family. Patients will then be enrolled and randomized. Patients in group A (surgery group) will follow the usual multidisciplinary bariatric surgery in adolescents. Patients in group B start conventional monitoring dietary medical and physical. For both groups follow-up visits will occur every 3 months for 2 years.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date November 2015
Est. primary completion date November 2015
Accepts healthy volunteers No
Gender Both
Age group 12 Years to 16 Years
Eligibility Inclusion Criteria:

1. Adolescents 12 to 16 years and with BMI and weight gain according to sex and age is greater than IMCZ-score > 4 DP> 8 kg

2. Obesity "common" non-syndromic.

3. Medical decision of surgical placement of laparoscopic gastric banding.

4. Adolescent and family who understand and accept the need for medical and surgical follow long term.

5. Adolescent and family who fully understood the oral and written information explaining the study and the need for prolonged follow-up.

6. Obtention of oral and written consent of the adolescent and the parents.

7. Parents and adolescents affiliated with the social security system.

EXCLUSION CRITERIA

1. Intellectual Deficit.

2. psychiatrics contraindication of surgical placement of laparoscopic gastric banding.

3. Obesity with severe binge eating.

4. Pregnancy or wishes of pregnancy in the following year.

5. Non accession adolescent and / or family in the process of medical care before inclusion.

6. Predictable post surgical monitoring difficulties.

7. Suspicion of physical abuse, verbal or negligence / deficiency in care of the family.

8. Participation in a clinical study evaluating a treatment during the 2 years of the study.

9. Anesthetic contre indication for placement of a gastric laparoscopic.

10. IMC> 50 kg/m2 the day of inclusion.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
gastric ring surgery

Other:
nutritional help


Locations

Country Name City State
France University Hospital of Angers Angers
France University Hospital of Caen Caen
France University hospital Bicêtre Le Kremlin Bicetre
France University Hospital of Lille Lille
France University Hospital of Necker Paris
France University Hospital of Toulouse Toulouse

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Angers

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary BMIZ-score evolution in 2 years. 2 years No
Secondary Evolution of quality of life scales 1, 2, 5 and 10 years No
Secondary Evaluation of des alimentary attitudinal troubles and psychiatrical troubles 1 year Yes
Secondary Evolution of BMIZ-score 1, 5 and 10 years No
Secondary Evolution of round-waist 1, 2, 5 and 10 years No
Secondary Evolution of bodily composition. 1, 2, 5 and 10 years No
Secondary Evolution of metabolic syndrome parameters. 1, 2, 5 and 10 years Yes
Secondary Evolution of respiratory parameters: polysomnography 2 years Yes
Secondary Determination of success factors of the ring. 2 years No
Secondary Study of tolerance of the gastric ring. 1, 2, 5 and 10 years Yes
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2